Comments
Loading...
Leap Therapeutics (LPTX) Forecast
NewsEarningsLeap Therapeutics (LPTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLeap Therapeutics (NASDAQ:LPTX) Stock Quotes, Forecast and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ:LPTX) through any online brokerage.
Who are Leap Therapeutics (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Invizyne Technologies (NASDAQ:IZTC), Anixa Biosciences (NASDAQ:ANIX), Adverum Biotechnologies (NASDAQ:ADVM), Inozyme Pharma (NASDAQ:INZY) and Citius Oncology (NASDAQ:CTOR).
What is the forecast, or price target, for Leap Therapeutics (LPTX) stock?
Leap Therapeutics has a consensus price target of $10.40.
What is the current price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $2.3095 last updated January 22, 2025 at 1:56 PM EST.
Does Leap Therapeutics (LPTX) pay a dividend?
There are no upcoming dividends for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q4 earnings are confirmed for Monday, March 17, 2025.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.